Shares of GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $20.68 and traded as low as $20.03. GENMAB A/S/S shares last traded at $20.92, with a volume of 1,872,721 shares.
GENMAB A/S/S Trading Up 6.2 %
The business’s fifty day simple moving average is $20.68 and its two-hundred day simple moving average is $23.22.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Further Reading
- Five stocks we like better than GENMAB A/S/S
- Why is the Ex-Dividend Date Significant to Investors?
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- How to Short a Stock in 5 Easy Steps
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What is a Low P/E Ratio and What Does it Tell Investors?
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
